Business
Johnson & Johnson gears up for collaboration on COVID vaccine supply – Sydney Morning Herald
The pharmaceutical giant is progressing development of its COVID vaccine, potentially giving Australia another option to import.
Pharmaceutical giant Johnson & Johnson is rapidly scaling up its manufacturing capabilities as it progresses development of its COVID vaccine and says it will be looking to work with governments to discuss fast-tracking supply if successful.
The vaccine hopeful is yet another option Australia will most likely have to negotiate to import if it wants supply, with the $US390 billion ($544 billion) biotech firm looking to the US and Europe for trials and broader manufacturing.
From AstraZeneca…
-
General22 hours agoHow they started and how they finished • Inside Story
-
Noosa News22 hours agoAustralian farmers express ‘profound disappointment’ as tariffs on Aussie beef backfires on Americans
-
Business21 hours agoWhich ASX sectors led the pack in March, according to Macquarie?
-
General20 hours agoTariff war. The world keeps turning despite Trump’s mayhem